CheckMate 577KEYNOTE-590Oesophageal cancerOesophageal squamous cell carcinoma (ESCC)ESCCImmune checkpoint inhibitors
…%. Immune checkpoint inhibitors, exemplified by KEYNOTE-590 and CheckMate 577 trials, have reshaped EC therapeutic landscapes. Our study addr…